The Advances in Molecular and New Point-of-Care (POC) Diagnosis of Schistosomiasis Pre- and Post-praziquantel Use: In the Pursuit of More Reliable Approaches for Low Endemic and Non-endemic Areas-Reference-Cited by-同舟云学术

The Advances in Molecular and New Point-of-Care (POC) Diagnosis of Schistosomiasis Pre- and Post-praziquantel Use: In the Pursuit of More Reliable Approaches for Low Endemic and Non-endemic Areas

Published:2019-05-28 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cavalcanti Marta G.,Cunha Aline Fernandes Araujo,Peralta José Mauro

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. Neglected Tropical Diseases

2. Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?;Colley;Infect Dis Poverty,2017

3. Schistosomiasis.2018

4. Fight Against Neglected Diseases Sets Sights on Parasites Transmitted by Livestock

5. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol;Tian-Bi;BMC Public Health.,2018

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of IL-1R2 by T follicular regulatory cells prevents the exacerbation of allergy by blocking their IL-1-dependent proliferation;2024-08-30

2. Development of a latex microsphere-based lateral flow immunoassay for the diagnosis of schistosomiasis japonica;2024-08-27

3. A Human Biomimetic Intestinal Mucosa Model to Study Gastrointestinal Development and Disease;2024-08-20

4. SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant tumor cells;2024-08-09

5. The Contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML);2024-07-30